cevostamab
roche
['mmsm', 'cevostamab']
good to see cevostamab used in fixed duration - the first bispecific *in myeloma* to show (preliminarily) durable responses with fixed-duration responses #ash22 #mmsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer